LOGIN  |  REGISTER
Viking Therapeutics
Compass Therapeutics

Solventum to Participate in Upcoming Investor Conferences

August 28, 2025 | Last Trade: US$80.68 0.73 0.91

ST. PAUL, Minn., Aug. 28, 2025 /PRNewswire/ -- Solventum (NYSE: SOLV) announced today that management will participate in fireside chats at the following investor conferences:

  • 2025 Wells Fargo Healthcare Conference in Boston, Mass., on Friday, Sept. 5, 2025, at 10:15 a.m. EDT.

  • Morgan Stanley 23rd Annual Global Healthcare Conference in New York, N.Y., on Tuesday, Sept. 9, 2025, at 10:45 a.m. EDT

Live and archived replays of the fireside chats will be available on the company's website at investors.solventum.com.

About Solventum

At Solventum, we enable better, smarter, safer healthcare to improve lives. As a new company with a long legacy of creating breakthrough solutions for our customers' toughest challenges, we pioneer game-changing innovations at the intersection of health, material and data science that change patients' lives for the better — while empowering healthcare professionals to perform at their best. See how at Solventum.com

Stock Quote

Featured Stock

ClearPoint Neuro

ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...

CLICK TO LEARN MORE

Featured Stock

Immix Biopharma

Immix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page